Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Alimera Sciences Inc COM NEW
ALIM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$5.54
0
0.00%
At close: Sep 13, 7:49 PM EDT
$5.54
0
0.00%
After Hours: Sep 13, 7:49 PM EDT
15 minutes delayed
Get Report
Comment
Alimera Sciences Inc COM NEW (ALIM) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Alimera Sciences Inc COM NEW (NASDAQ:ALIM) Stock
Alimera Sciences Inc COM NEW Stock (NASDAQ: ALIM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, September 11, 2024
ANI Pharmaceuticals And Alimera Sciences Anno...
Benzinga Newsdesk
Tuesday, September 10, 2024
Crude Oil Dips Over 4%; OPEC Cuts Global Oil Demand Outlook
Avi Kapoor
Dow Dips Around 1%; US Small Business Optimism Falls In August
Avi Kapoor
Alimera Sciences shares are trading lower aft...
Benzinga Newsdesk
Alimera Sciences Takes Legal Action Against A...
Benzinga Newsdesk
Monday, September 09, 2024
Trading Halt: Halt status updated at 8:50:00 ...
Benzinga Newsdesk
Tuesday, August 06, 2024
Alimera Sciences Q2 2024 GAAP EPS $(0.06) Mis...
Benzinga Newsdesk
Tuesday, June 25, 2024
Alliance Global Partners Downgrades Alimera S...
Benzinga Newsdesk
Maxim Group Downgrades Alimera Sciences to Ho...
Benzinga Newsdesk
HC Wainwright & Co. Downgrades Alimera Scienc...
Benzinga Newsdesk
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
Avi Kapoor
Monday, June 24, 2024
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher
Avi Kapoor
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
Vandana Singh
Alimera Sciences shares are trading higher af...
Benzinga Newsdesk
ANI Pharma to Snap Alimera Sciences Valuing T...
Benzinga Newsdesk
Thursday, May 16, 2024
HC Wainwright & Co. Reiterates Buy on Alimera...
Benzinga Newsdesk
Tuesday, May 14, 2024
Alimera Sciences Reports Q1 Loss, Misses Revenue Estimates
Zacks
Alimera Sciences Q1 EPS $(0.12) Misses $(0.06...
Benzinga Newsdesk
Tuesday, May 07, 2024
Alimera Announces Scientific Data Highlightin...
Benzinga Newsdesk
Monday, March 25, 2024
Maxim Group Initiates Coverage On Alimera Sci...
Benzinga Newsdesk
Tuesday, March 19, 2024
Alimera Announces First Patient Randomized In...
Benzinga Newsdesk
Friday, March 08, 2024
HC Wainwright & Co. Maintains Buy on Alimera ...
Benzinga Newsdesk
Thursday, March 07, 2024
Alimera Sciences Expects 2024 Revenue Over $1...
Benzinga Newsdesk
Alimera Sciences Q4 EPS $(0.07) Up From $(0.5...
Benzinga Newsdesk
Earnings Scheduled For March 7, 2024
Benzinga Insights
Wednesday, March 06, 2024
A Preview Of Alimera Sciences's Earnings
Benzinga Insights
Thursday, February 08, 2024
The UK National Institute For Health And Care...
Benzinga Newsdesk
Thursday, January 04, 2024
Alimera Completes Recruitment For The Synchro...
Benzinga Newsdesk
Tuesday, January 02, 2024
Alimera Sciences Appoints Elliot Maltz As CFO...
Benzinga Newsdesk
Wednesday, November 29, 2023
Chief Financial Officer & SVP at Alimera Sciences Acquires Company Stock Options Worth 50,000 Shares
Benzinga Insights
Chief Operating Officer & SVP at Alimera Sciences Acquires Company Stock Options Worth 147,000 Shares
Benzinga Insights
Alimera Sciences Chief Marketing Officer & SVP Awarded $302K Worth of Stock Options
Benzinga Insights
Tuesday, October 31, 2023
Alimera Announces Scientific Data Highlightin...
Benzinga Newsdesk
Thursday, October 26, 2023
Earnings Scheduled For October 26, 2023
Benzinga Insights
Alimera Sciences Q3 EPS $(0.06) Vs $(0.75) La...
Benzinga Newsdesk
Wednesday, October 11, 2023
Alimera Announces Multiple Presentations High...
Benzinga Newsdesk
Thursday, October 05, 2023
Board Member at Alimera Sciences Acquires Company Stock Options Worth 50,000 Shares
Benzinga Insights
Tuesday, October 03, 2023
On October 3, 2023, Alimera Sciences Appointe...
Benzinga Newsdesk
Monday, August 14, 2023
The Latest Analyst Ratings for Alimera Sciences
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Alimera...
Benzinga Newsdesk
Thursday, August 10, 2023
Alimera Sciences Q2 EPS $(1.32) Misses $0.06 ...
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Benzinga Insights
Wednesday, August 09, 2023
Preview: Alimera Sciences's Earnings
Benzinga Insights
Monday, June 12, 2023
Alliance Global Partners Upgrades Alimera Sciences: Here's What You Need To Know
Benzinga Insights
Alimera Sciences shares are trading higher af...
Benzinga Newsdesk
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023
Benzinga Insights
10 Short Squeeze Stocks To Watch: Getty Images, Intuitive Machines, Wearable Devices & More
Chris Katje
Expert Ratings for Alimera Sciences
Benzinga Insights
Alliance Global Partners Upgrades Alimera Sci...
Benzinga Newsdesk
Friday, June 09, 2023
On June 7, 2023, Nasdaq Notified Alimera Scie...
Happy Mohamed
Show More